Global Diabetes Associated Ophthalmic Treatment Market Size, Share, and COVID-19 Impact Analysis, By Type (Devices, Drugs), By Application (Glaucoma, Diabetic Retinopathy, Eye Allergy & Infection, Dry Eye Syndrome, Diabetic Associated Macular Degeneration, Cataract, Uveitis), By End-Use (Ambulatory Surgical Centers, Hospitals, and Ophthalmic Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Aug 2024
REPORT ID SI5802
PAGES 273
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type
      2. Market Attractiveness Analysis By Application
      3. Market Attractiveness Analysis By End-Use
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increase in incidence of diabetes.
    3. Restraints
      1.  Expensive treatment procedures.
    4. Opportunities
      1.  Increased R&D to develop cost-effective novel diabetic medicines
    5. Challenges
      1. Optimizing therapies and educating people about self-management.
  6. Global Diabetes Associated Ophthalmic Treatment Market Analysis and Projection, By Type
    1. Segment Overview
    2. Devices
    3. Drugs
  7. Global Diabetes Associated Ophthalmic Treatment Market Analysis and Projection, By Application
    1. Segment Overview
    2. Glaucoma
    3. Diabetic Retinopathy
    4. Eye Allergy & Infection
    5. Dry Eye Syndrome
    6. Diabetic Associated Macular Degeneration
    7.  Cataract
    8.  Uveitis
  8. Global Diabetes Associated Ophthalmic Treatment Market Analysis and Projection, By End-Use
    1. Segment Overview
    2. Ambulatory Surgical Centers
    3. Hospitals
    4. Ophthalmic Centers
  9. Global Diabetes Associated Ophthalmic Treatment Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Diabetes Associated Ophthalmic Treatment Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Diabetes Associated Ophthalmic Treatment Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. F. Hoffmann-La Roche Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Johnson & Johnson Services, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  AbbVie Inc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Novartis AG 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Quantel 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Pfizer, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Ellex Medical Lasers Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Bausch Health Companies Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Carl Zeiss Meditec
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Abbott Medical Optics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Genentech, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Bayer AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Alcon 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Topcon Corp
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. IRIDEX Corp. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    16. Lumenis 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  2. Global Devices, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  3. Global Drugs, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  4. Global Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  5. Global Glaucoma, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  6. Global Diabetic Retinopathy, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  7. Global Eye Allergy & Infection, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  8. Global Dry Eye Syndrome, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  9. Global Diabetic Associated Macular Degeneration, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  10. Global Cataract, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  11. Global Uveitis , Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  12. Global Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  13. Global Ambulatory Surgical Centers, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  14. Global Hospitals, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  15. Global Ophthalmic Centers, Diabetes Associated Ophthalmic Treatment Market, By Region, 2023-2033(USD Billion)
  16. North America Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  17. North America Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  18. North America Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  19. U.S.  Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  20. U.S.  Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  21. U.S.  Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  22. Canada Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  23. Canada Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  24. Canada Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  25. Mexico Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  26. Mexico Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  27. Mexico Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  28. Europe Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  29. Europe Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  30. Europe Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  31. Germany Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  32. Germany Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  33. Germany Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  34. France Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  35. France Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  36. France Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  37. U.K.  Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  38. U.K.  Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  39. U.K.  Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  40. Italy Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  41. Italy Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  42. Italy Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  43. Spain Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  44. Spain Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  45. Spain Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  46. Asia Pacific Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  47. Asia Pacific Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  48. Asia Pacific Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  49. Japan Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  50. Japan Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  51. Japan Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  52. China Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  53. China Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  54. China Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  55. India Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  56. India Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  57. India Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  58. South America Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  59. South America Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  60. South America Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  61. Brazil Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  62. Brazil Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  63. Brazil Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  64. The Middle East and Africa Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD   Billion)
  65. The Middle East and Africa Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD   Billion)
  66. The Middle East and Africa Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  67. UAE Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  68. UAE Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  69. UAE Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)
  70. South Africa Diabetes Associated Ophthalmic Treatment Market, By Type, 2023-2033(USD Billion)
  71. South Africa Diabetes Associated Ophthalmic Treatment Market, By Application, 2023-2033(USD Billion)
  72. South Africa Diabetes Associated Ophthalmic Treatment Market, By End-Use, 2023-2033(USD Billion)

List of Figures 

  1. Global Diabetes Associated Ophthalmic Treatment Market Segmentation
  2. Diabetes Associated Ophthalmic Treatment Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Diabetes Associated Ophthalmic Treatment Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Diabetes Associated Ophthalmic Treatment Market
  20. Diabetes Associated Ophthalmic Treatment Market Segmentation, By Type
  21. Diabetes Associated Ophthalmic Treatment Market For Devices, By Region, 2023-2033 ($ Billion)
  22.  Diabetes Associated Ophthalmic Treatment Market For Drugs, By Region, 2023-2033 ($ Billion)
  23. Diabetes Associated Ophthalmic Treatment Market Segmentation, By Application
  24.  Diabetes Associated Ophthalmic Treatment Market For Glaucoma, By Region, 2023-2033 ($ Billion)
  25.  Diabetes Associated Ophthalmic Treatment Market For Diabetic Retinopathy, By Region, 2023-2033 ($ Billion)
  26. Diabetes Associated Ophthalmic Treatment Market For Eye Allergy & Infection, By Region, 2023-2033 ($ Billion)
  27. Diabetes Associated Ophthalmic Treatment Market For Dry Eye Syndrome, By Region, 2023-2033 ($ Billion)
  28. Diabetes Associated Ophthalmic Treatment Market For Diabetic Associated Macular Degeneration, By Region, 2023-2033 ($ Billion)
  29. Diabetes Associated Ophthalmic Treatment Market For Cataract, By Region, 2023-2033 ($ Billion)
  30. Diabetes Associated Ophthalmic Treatment Market For Uveitis, By Region, 2023-2033 ($ Billion)
  31. Diabetes Associated Ophthalmic Treatment Market Segmentation, By End-Use
  32. Diabetes Associated Ophthalmic Treatment Market For Ambulatory Surgical Centers, By Region, 2023-2033 ($ Billion)
  33. Diabetes Associated Ophthalmic Treatment Market For Hospitals, By Region, 2023-2033 ($ Billion)
  34. Diabetes Associated Ophthalmic Treatment Market For Opthalmic Centres, By Region, 2023-2033 ($ Billion)
  35. F. Hoffmann-La Roche Ltd: Net Sales, 2023-2033 ($ Billion)
  36. F. Hoffmann-La Roche Ltd: Revenue Share, By Segment, 2023 (%)
  37. F. Hoffmann-La Roche Ltd: Revenue Share, By Region, 2023 (%)
  38. Johnson & Johnson Services, Inc.: Net Sales, 2023-2033 ($ Billion)
  39. Johnson & Johnson Services, Inc.: Revenue Share, By Segment, 2023 (%)
  40. Johnson & Johnson Services, Inc.: Revenue Share, By Region, 2023 (%)
  41. AbbVie Inc: Net Sales, 2023-2033 ($ Billion)
  42. AbbVie Inc: Revenue Share, By Segment, 2023 (%)
  43. AbbVie Inc: Revenue Share, By Region, 2023 (%)
  44. Novartis AG: Net Sales, 2023-2033 ($ Billion)
  45. Novartis AG: Revenue Share, By Segment, 2023 (%)
  46. Novartis AG: Revenue Share, By Region, 2023 (%)
  47. Quantel: Net Sales, 2023-2033 ($ Billion)
  48. Quantel: Revenue Share, By Segment, 2023 (%)
  49. Quantel: Revenue Share, By Region, 2023 (%)
  50. Pfizer, Inc.: Net Sales, 2023-2033 ($ Billion)
  51. Pfizer, Inc.: Revenue Share, By Segment, 2023 (%)
  52. Pfizer, Inc.: Revenue Share, By Region, 2023 (%)
  53. Ellex Medical Lasers Ltd.: Net Sales, 2023-2033 ($ Billion)
  54. Ellex Medical Lasers Ltd.: Revenue Share, By Segment, 2023 (%)
  55. Ellex Medical Lasers Ltd.: Revenue Share, By Region, 2023 (%)
  56. Bausch Health Companies Inc.: Net Sales, 2023-2033 ($ Billion)
  57. Bausch Health Companies Inc.: Revenue Share, By Segment, 2023 (%)
  58. Bausch Health Companies Inc.: Revenue Share, By Region, 2023 (%)
  59. Carl Zeiss Meditec.: Net Sales, 2023-2033 ($ Billion)
  60. Carl Zeiss Meditec.: Revenue Share, By Segment, 2023 (%)
  61. Carl Zeiss Meditec.: Revenue Share, By Region, 2023 (%)
  62. Abbott Medical Optics: Net Sales, 2023-2033 ($ Billion)
  63. Abbott Medical Optics: Revenue Share, By Segment, 2023 (%)
  64. Abbott Medical Optics: Revenue Share, By Region, 2023 (%)
  65. Genentech, Inc.: Net Sales, 2023-2033 ($ Billion)
  66. Genentech, Inc.: Revenue Share, By Segment, 2023 (%)
  67. Genentech, Inc.: Revenue Share, By Region, 2023 (%)
  68. Bayer AG: Net Sales, 2023-2033 ($ Billion)
  69. Bayer AG: Revenue Share, By Segment, 2023 (%)
  70. Bayer AG: Revenue Share, By Region, 2023 (%)
  71. Alcon: Net Sales, 2023-2033 ($ Billion)
  72. Alcon: Revenue Share, By Segment, 2023 (%)
  73. Alcon: Revenue Share, By Region, 2023 (%)
  74. Topcon Corp.: Net Sales, 2023-2033 ($ Billion)
  75. Topcon Corp.: Revenue Share, By Segment, 2023 (%)
  76. Topcon Corp.: Revenue Share, By Region, 2023 (%)
  77.  IRIDEX Corp.: Net Sales, 2023-2033 ($ Billion)
  78.  IRIDEX Corp.: Revenue Share, By Segment, 2023 (%)
  79.  IRIDEX Corp.: Revenue Share, By Region, 2023 (%)
  80.  Lumenis: Net Sales, 2023-2033 ($ Billion)
  81.  Lumenis: Revenue Share, By Segment, 2023 (%)
  82.  Lumenis: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:273
Countries covered:17
Companies covered::20
Forecast CAGR:6.61%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies